You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 5, November 1956 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Endocrine Aspects of Exophthalmos

EDWARD ROSE, M.D.

AMA Arch Ophthalmol. 1956;56(5):668-670.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This discussion will be limited to the unique constellation of ophthalmopathic phenomena in which exophthalmos is only one of several manifestations and which has been known variously as malignant or progressive exophthalmos, hyperophthalmopathic Graves' disease, exophthalmic ophthalmoplegia, and the infiltrative ophthalmopathy of Graves' disease. It is usually accompanied by hyperthyroidism but may occur in euthyroid persons or occasionally in patients who are in a hypothyroid state throughout. Milder variants of the syndrome have even been described in Cushing's disease. After more than a century of fruitless speculation concerning its etiology and pathogenesis, interest began to center on the adenohypophysis as an important factor about 20 years ago, and in 1944 the nosological concept of Mulvany1 further influenced this trend of thought. This concept divided exophthalmos into thyrotoxic and thyrotropic types. The former (thyrotoxic) included the milder syndromes manifested chiefly by exophthalmos, lid retraction, and thinning of the extrinsic muscles; . . . [Full Text PDF of this Article]


Author Affiliations

Philadelphia

Professor of Clinical Medicine, School of Medicine, University of Pennsylvania; Chief, Endocrine Section, Medical Clinic, Hospital of the University of Pennsylvania.


Footnotes

Received for publication June 4, 1956.

Read in the Symposium on Management of Exophthalmos before the Sectional Meeting of the American College of Surgeons, Philadelphia, Feb. 16, 1956.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1956 American Medical Association. All Rights Reserved.